# TEZSPIRE

NDC: 55513-112
Generic name: tezepelumab-ekko
Labeler / Manufacturer: Amgen Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20211217

FDA application: BLA761224

## Active ingredients

- TEZEPELUMAB: 210 mg/1.9mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-112"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-112
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60f0aa03-ad25-4d48-80ce-7fcfa76f325f